MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Accuray Incorporated Cash and Cash Equivalents 2011-2026 | ARAY
Annual Cash and Cash Equivalents Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.4 M | 68.6 M | 89.4 M | 90.2 M | 118 M | 110 M | 76.8 M | 83.1 M | 72.1 M | 120 M | 79.6 M | 92.3 M | 73.3 M | 144 M | 95.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | 57.4 M | 91.3 M |
Quarterly Cash and Cash Equivalents Accuray Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.3 M | 57.4 M | 77.8 M | 62.6 M | 61.1 M | 68.6 M | 62.2 M | 74.5 M | 78.7 M | 89.4 M | 90.8 M | 69.2 M | 82.4 M | 88.7 M | 99.3 M | 125 M | 106 M | 118 M | 116 M | 107 M | 90 M | 108 M | 108 M | 96.4 M | 80.9 M | 76.8 M | 76.8 M | 59.4 M | 68.5 M | 83.1 M | 83.1 M | 79.5 M | 67.9 M | 72.1 M | 72.1 M | 69.5 M | 83.6 M | 120 M | 120 M | 88.5 M | 85.6 M | 88.5 M | 85.6 M | 97.3 M | 107 M | 97.3 M | 107 M | 70.4 M | 62.4 M | 70.4 M | 62.4 M | 94.8 M | 122 M | 94.8 M | 122 M | 148 M | 140 M | 148 M | 140 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 148 M | 57.4 M | 90.6 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
233 M | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
139 M | $ 21.04 | 0.86 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 9.39 | 0.97 % | $ 674 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
414 M | $ 95.46 | -0.55 % | $ 140 B | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 302.69 | -0.7 % | $ 8.54 B | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 47.37 | -0.29 % | $ 7.06 K | USA |
 |
Abbott Laboratories
ABT
|
7.62 B | $ 125.42 | -0.31 % | $ 218 B | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.29 | 2.34 % | $ 123 M |  France |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
15.3 M | $ 29.28 | 1.1 % | $ 248 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
68.9 M | $ 14.75 | -0.64 % | $ 1.17 B | Israel |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Zynex
ZYXI
|
39.6 M | - | - | $ 21.1 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 156.53 | -1.02 % | $ 11.7 B | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 13.5 | -0.52 % | $ 365 M | USA |
 |
FONAR Corporation
FONR
|
46.8 M | $ 18.58 | -0.13 % | $ 122 M | USA |
 |
AxoGen
AXGN
|
27.6 M | $ 32.74 | 0.03 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.12 | -2.61 % | $ 18.1 M | USA |
 |
IRadimed Corporation
IRMD
|
52.2 M | $ 97.43 | -0.35 % | $ 1.23 B | USA |
 |
CONMED Corporation
CNMD
|
24.5 M | $ 40.65 | -1.2 % | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
43.8 M | $ 17.74 | -1.25 % | $ 409 M | USA |
 |
Globus Medical
GMED
|
784 M | $ 87.52 | -0.4 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 12.42 | -2.09 % | $ 956 M | USA |
 |
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.73 | 1.49 % | $ 4.26 M | USA |
 |
LivaNova PLC
LIVN
|
429 M | $ 61.42 | -1.39 % | $ 3.33 B |  Britain |